Allysson Thiago Cramer Soares

Dr. Allysson Thiago Cramer Soares

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
IZIsabella Zaidan
Isabella Zaidan
Luciana TavaresLuciana Tavares
Luciana Tavares
MFMichelle De Freitas
Michelle De Freitas
KLKátia M. Lima
Kátia M. Lima
GNGraziele L. Negreiros-Lima
Graziele L. Negreiros-Lima
Lirlândia SousaLirlândia Sousa
Lirlândia Sousa
Nonphlogistic migration of macrophages contributes to the clearance of pathogens and apoptotic cells, a critical step for the resolution of inflammation and return to homeostasis. Angiotensin-(1-7) [Ang-(1-7)] is a heptapeptide of the renin-angiotensin system that acts through Mas receptor (MasR). Ang-(1-7) has recently emerged as a novel proresolving mediator, yet Ang-(1-7) resolution mechanisms are not fully determined. Herein, Ang-(1-7) stimulated migration of human and murine monocytes/macrophages in a MasR-, CCR2-, and MEK/ERK1/2–dependent manner. Pleural injection of Ang-(1-7) promoted nonphlogistic mononuclear cell influx alongside increased levels of CCL2, IL-10, and macrophage polarization toward a regulatory phenotype. Ang-(1-7) induction of CCL2 and mononuclear cell migration was also dependent on MasR and MEK/ERK. Of note, MasR was upregulated during the resolution phase of inflammation, and its pharmacological inhibition or genetic deficiency impaired mononuclear cell recruitment during self-resolving models of LPS pleurisy and E . coli peritonitis. Inhibition/absence of MasR was associated with reduced CCL2 levels, impaired phagocytosis of bacteria, efferocytosis, and delayed resolution of inflammation. In summary, we have uncovered a potentially novel proresolving feature of Ang-(1-7), namely the recruitment of mononuclear cells favoring efferocytosis, phagocytosis, and resolution of inflammation. Mechanistically, cell migration was dependent on MasR, CCR2, and the MEK/ERK pathway.

23 December 2019 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
ASAllysson Thiago Cramer Soares
Allysson Thiago Cramer Soares
BOBruno Cabral de Lima Oliveira
Bruno Cabral de Lima Oliveira
PLPaulo Gaio Leite
Paulo Gaio Leite
DRDavid Henrique Rodrigues
David Henrique Rodrigues
FBFatima Brant
Fatima Brant
FMFabiana Simão Machado
Fabiana Simão Machado
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS). Experimental Autoimmune Encephalomyelitis (EAE) is the most widely used animal model for the study of MS. The Suppressor of Cytokine Signaling (SOCS) 2 protein plays a critical role in regulating the immune responses. The role of SOCS2 during EAE has not been explored. EAE was induced in WT and SOCS2-/- mice using myelin oligodendrocyte glycoprotein (MOG35-55) peptide. Brain and spinal cord were examined during the peak (day 14) and recovery phase (day 28) of the disease. SOCS2 was upregulated in the brain of WT mice at the peak and recovery phase of EAE. The development of the acute phase was slower in onset in SOCS2-/- mice and was associated with reduced number of Th1 (CD3+CD4+IFN-γ+) cells in the spinal cord and brain. However, while in WT mice, maximal clinical EAE score was followed by a progressive recovery; the SOCS2-/- mice were unable to recover from locomotor impairment that occurred during the acute phase. There was a prolonged inflammatory response (increased Th1 and decreased Th2 and T regulatory cells) in the late phase of EAE in the CNS of SOCS2-/- mice. Transplantation of bone marrow cells from SOCS2-/- into irradiated WT mice resulted in higher lethality at the early phase of EAE. Altogether, these results suggest that SOCS2 plays a dual role in the immune response during EAE. It is necessary for damage during the acute phase damage but plays a beneficial role in the recovery stage of the disease.

22 March 2017 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RMRafael Elias Marques
Rafael Elias Marques
JSJuliana Del Sarto
Juliana Del Sarto
RRRebeca de Paiva Froes Rocha
Rebeca de Paiva Froes Rocha
GGGiovanni Freitas Gomes
Giovanni Freitas Gomes
ASAllysson Thiago Cramer Soares
Allysson Thiago Cramer Soares
MTMauro Martins Teixeira
Mauro Martins Teixeira
Flaviviruses are a genre of closely related viral pathogens which emerged in the last decades in Brazil and in the world. Saint (St.) Louis encephalitis virus (SLEV) is a neglected flavivirus that can cause a severe neurological disease that may lead to death or sequelae. St. Louis encephalitis pathogenesis is poorly understood, which hinders the development of specific treatment or vaccine. To address this problem, we developed a model of SLEV infection in mice to study mechanisms involved in the pathogenesis of severe disease. The model consists in the intracranial inoculation of the SLEV strain BeH 355964, a strain isolated from a symptomatic human patient in Brazil, in adult immunocompetent mice. Inoculated mice presented SLEV replication in the brain, accompanied by tissue damage, disease signs, and mortality approximately 7 days post infection. Infection was characterized by the production of proinflammatory cytokines and interferons and by leukocyte recruitment to the brain, composed mainly by neutrophils and lymphocytes. In vitro experiments indicated that SLEV is able to replicate in both neurons and glia and caused neuronal death and cytokine production, respectively. Altogether, intracranial SLEV infection leads to meningoencephalitis in mice, recapitulating several aspects of St. Louis encephalitis in humans. Our study indicates that the central nervous system (CNS) inflammation is a major component of SLEV-induced disease. This model may be useful to identify mechanisms of disease pathogenesis or resistance to SLEV infection.

2 June 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ASArtur Santos-Miranda
Artur Santos-Miranda
JJJulliane V. Joviano-Santos
Julliane V. Joviano-Santos
JSJaqueline O. Sarmento
Jaqueline O. Sarmento
ACAlexandre D. Costa
Alexandre D. Costa
ASAllysson Thiago Cramer Soares
Allysson Thiago Cramer Soares
DRDanilo Roman-Campos
Danilo Roman-Campos
Background: Chagas disease (CD) is a neglected disease that induces heart failure and arrhythmias in approximately 30% of patients during the chronic phase of the disease. Despite major efforts to understand the cellular pathophysiology of CD there are still relevant open questions to be addressed. In the present investigation we aimed to evaluate the contribution of the Na+/Ca2+ exchanger (NCX) in the electrical remodeling of isolated cardiomyocytes from an experimental murine model of chronic CD. Methodology/Principal findings: Male C57BL/6 mice were infected with Colombian strain of Trypanosoma cruzi. Experiments were conducted in isolated left ventricular cardiomyocytes from mice 180–200 days post-infection and with age-matched controls. Whole-cell patch-clamp technique was used to measure cellular excitability and Real-time PCR for parasite detection. In current-clamp experiments, we found that action potential (AP) repolarization was prolonged in cardiomyocytes from chagasic mice paced at 0.2 and 1 Hz. After-depolarizations, both subthreshold and with spontaneous APs events, were more evident in the chronic phase of experimental CD. In voltage-clamp experiments, pause-induced spontaneous activity with the presence of diastolic transient inward current was enhanced in chagasic cardiomyocytes. AP waveform disturbances and diastolic transient inward current were largely attenuated in chagasic cardiomyocytes exposed to Ni2+ or SEA0400. Conclusions/Significance: The present study is the first to describe NCX as a cellular arrhythmogenic substrate in chagasic cardiomyocytes. Our data suggest that NCX could be relevant to further understanding of arrhythmogenesis in the chronic phase of experimental CD and blocking NCX may be a new therapeutic strategy to treat arrhythmias in this condition.

27 December 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PLPaulo Gaio Leite
Paulo Gaio Leite
ASAllysson Thiago Cramer Soares
Allysson Thiago Cramer Soares
NONatalia Fernanda de Melo Oliveira
Natalia Fernanda de Melo Oliveira
SPSamuel Porto
Samuel Porto
LKLucas Kramer
Lucas Kramer
FMFabiana Simão Machado
Fabiana Simão Machado
Plasmodium berghei ANKA (PbA) infection in mice resembles several aspects of severe malaria in humans, such as cerebral malaria and acute respiratory distress syndrome. Herein, the effects of N-(coumarin-3-yl)cinnamamide (M220) against severe experimental malaria have been investigated. Treatment with M220 proved to protect cognitive abilities and lung function in PbA-infected mice, observed by an object recognition test and spirometry, respectively. In addition, treated mice demonstrated decreased levels of brain and lung inflammation. The production and accumulation of microglia, and immune cells that produce the inflammatory cytokines TNF and IFN-γ, decreased, while the production of the anti-inflammatory cytokine IL-10 by innate and adaptive immune cells was enhanced. Treatment with M220 promotes immunomodulatory, neuroprotective, and lung function-preserving effects during experimental severe malaria. Therefore, it may be an interesting therapeutic candidate to treat severe malaria effects.

1 May 2017 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
FGFabiola González-Herrera
Fabiola González-Herrera
ASAllysson Thiago Cramer Soares
Allysson Thiago Cramer Soares
PPPollyana Pimentel
Pollyana Pimentel
CCChristian Castillo
Christian Castillo
ALana liempi
ana liempi
JMJuan Diego Maya
Juan Diego Maya